Hodgkin lymphoma (HL) is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. 5-year relative survival rates for Hodgkin lymphoma.

In a few cases, chemotherapy may be combined with steroid medication. Surgery isn't generally used to treat the condition, except for the biopsy used to diagnose it. Overall, treatment for Hodgkin lymphoma is highly effective and most people with the condition are eventually cured.

Hodgkin's lymphoma is recognized as one of the most treatable cancers, with over 90% of patients surviving more than five years. Non-Hodgkin's, however, often arises in various parts of the body. It can surface in similar lymph nodes as Hodgkin's lymphoma, or even in the groin and abdomen.

Hodgkin lymphoma is considered one of the most treatable cancers, with more than 90 percent of patients surviving more than five years. Most patients with Hodgkin lymphoma live long and healthy lives following successful treatment.

Most people with indolent non-Hodgkin lymphoma will live 20 years after diagnosis. Faster-growing cancers (aggressive lymphomas) have a worse prognosis. They fall into the overall five-year survival rate of 60%.

Hodgkin lymphoma is a relatively aggressive cancer and can quickly spread through the body. Despite this, it's also one of the most easily treated types of cancer. Your recommended treatment plan will depend on your general health and age, because many of the treatments can put a tremendous strain on the body.

These grow so slowly that patients can live for many years mostly without symptoms, although some may experience pain from an enlarged lymph gland. After five to 10 years, low-grade disorders begin to progress rapidly to become aggressive or high-grade and produce more severe symptoms.

These cells travel through the lymphatic system, which is part of the body's immune system. As with many cancers, there are four stages of lymphoma. Stage 4 (IV) lymphoma is often treatable. A person's prognosis depends on many factors, which include the type of lymphoma and the age of the individual.

Treatment for many patients is chemotherapy (usually 2 to 4 cycles of the ABVD regimen), followed by radiation to the initial site of the disease (involved site radiation therapy, or ISRT). Another option is chemotherapy alone (usually for 3 to 6 cycles) in selected patients.

So do share your valuable research in our Journal of Biochemistry & Biotechnology  which is an open-access journal dedicating the research in the area of biochemistry & biotechnology. We have been publishing the articles which are having updated information on biological science.

Allied Academics is one of the leading publishers operates a journal portfolio focusing on biomedical, environment, finance and marketing subjects. The main aim is to publish Original, peer-reviewed articles, Review articles, Short Communication, Editorials, Case Reports etc., following internationally recognized standard editorial guidelines, publication ethics, and production policies. Several authors affiliated to reputed organizations, institutions, government bodies have published their valuable contributions with Allied Academies.

The manuscripts may be submitted as an attachment to biochembiotech[at]scholarlypub[dot]com; aabb[at]alliedjournals[dot]org  

Regards,
Nicola B
Editorial Team
Journal of  Biochemistry and Biotechnology